Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects
Status:
Completed
Trial end date:
2021-01-27
Target enrollment:
Participant gender:
Summary
This study is objective to evaluate the in vivo absorption, excretion and biotransformation
pathways of [14C]-TPN171H in Chinese male healthy volunteers, and to reveal the overall
pharmacokinetic characteristics of TPN171H in human body, so as to provide basis for rational
use of the drug.
Phase:
Phase 1
Details
Lead Sponsor:
Vigonvita Life Sciences
Collaborator:
Shanghai Institute of Materia Medica, Chinese Academy of Sciences